Moderate to Severe Asthma

Also known as: Moderate/Severe Asthma / Moderate-to-Severe Asthma

DrugDrug NameDrug Description
DB12159DupilumabA monoclonal antibody used to treat moderate to severe atopic dermatitis, asthma, and nasal polyps accompanied by chronic rhinosinusitis in adolescents and adults.
DrugDrug NamePhaseStatusCount
DB18855Povorcitinib2Recruiting1
DB18990Stapokibart2 / 3Recruiting1
DB15090Tezepelumab3Completed1
DB12023Benralizumab4Recruiting1
DB12159Dupilumab4Recruiting1